Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Vegas Kate who wrote (22716)	1/22/1999 9:49:00 AM
From: SMALL FRY	Read Replies (2) \| Respond to of 120523

ERTS, SYBS, PVSW, ITWO looking strong. SF

To: Vegas Kate who wrote (22716)	1/22/1999 9:58:00 AM
From: wiz	Respond to of 120523

Vagas Kate SIII earnings released next monday after the bell. Much of SIII run up due to patents they hold on the Intel Merced chip. To go higher they will need to show the street that they can compete in the graphics market. So far not allot to go on. earnings, and comments made will be pretty key! Mark

To: Vegas Kate who wrote (22716)	1/22/1999 6:13:00 PM
From: Jenna	Respond to of 120523

SIII.. I like it, but it hard to even track each and every one of my own picks so lots of times they get relagated to the back burner when something else comes along. That is why I can't always update you on every stock's progress. I keep the watch lists short and the ones I post on SI are short that way you can track the stocks yourself without wading through scores of watch lists picks.

To: Vegas Kate who wrote (22716)	1/22/1999 6:21:00 PM
From: Jenna	Read Replies (1) \| Respond to of 120523

<<free subscription opportunity>> Biotechnology/Drug sector gurus..Because of unusual developments in the biotechnology and drug sector I need a researcher much like Kha Vu in the technology sector that can keep Market Gems Stock Selections site and this thread abreast of pending developments in various stocks. We need both technical analysis, earnings, and new product updates and tracking FDA approvals, etc.. We need to keep it in layman's terms so I won't even go onto a biotechnology thread unless someone can recommend a particular person to me. I can offer a year's subscription worth $350 for just a few hours a week work but you should be really knowledgeable in the sector and its advancements.